Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet

British Journal of Nutrition

Volumn 102, Issue 7, 2009, Pages 995-1006

  Rokling Andersen, Merethe H ^a   Rustan, Arild C ^a   Wensaas, Andreas J ^a   Kaalhus, Olav ^b   Wergedahl, Hege ^c   Røst, Therese H ^c,d   Jensen, Jørgen ^e   Graff, Bjørn A ^f   Caesar, Robert ^a   Drevon, Christian A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^f NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

Author keywords

Body composition; Gene expression; Marine n 3 fatty acids; Visceral adipose depots

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE II; CHEMOKINE; CYTOKINE; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID SYNTHASE; INSULIN; LIPID; MESSENGER RNA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; BUTTER; CONTROLLED STUDY; EPIDIDYMIS; FOOD INTAKE; GENE EXPRESSION; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; KIDNEY; LIPID BLOOD LEVEL; LIPID DIET; LIVER PARENCHYMA; MALE; MESENTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; WEIGHT GAIN; WISTAR RAT;

ADIPOKINES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BODY COMPOSITION; BODY WEIGHT; CYTOKINES; DIET; DIETARY FATS; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOGEN; LIPID METABOLISM; LIPIDS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 73749088581     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509353210     Document Type: Article

References (48)

1. Rustan AC, Hustvedt BE & Drevon CA (1998) Postprandial decrease in plasma unesterified fatty acids during n-3 fatty acid feeding is not caused by accumulation of fatty acids in adipose tissue. Biochim Biophys Acta 1390, 245-257.
2. Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, Suppl., 1645S-1654S.
3. Harris WS (1997) n-3 Fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr 65, Suppl., 1611S-1616S.
4. Rustan AC, Nossen JO, Osmundsen H, et al. (1988) Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J Biol Chem 263, 8126-8132.
5. Nossen JO, Rustan AC, Gloppestad SH, et al. (1986) Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. Biochim Biophys Acta 879, 56-65.
6. Rustan AC, Nossen JO, Christiansen EN, et al. (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res 29, 1417-1426.
7. Ukropec J, Reseland JE, Gasperikova D, et al. (2003) The hypotriglyceridemic effect of dietary n-3 FA is associated with increased b-oxidation and reduced leptin expression. Lipids 38, 1023-1029.
8. Rustan AC, Hustvedt BE & Drevon CA (1993) Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 34, 1299-1309.
9. Yusuf S, Hawken S, Ounpuu S, et al. (2005) Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 366, 1640-1649.
10. Lafontan M & Berlan M (2003) Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 24, 276-283.
11. Belzung F, Raclot T & Groscolas R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264, R1111-R1118.
12. Hill JO, Peters JC, Lin D, et al. (1993) Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 17, 223-236.
13. Parrish CC, Pathy DA & Angel A (1990) Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 39, 217-219.
14. Cannon B & Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84, 277-359.
15. Dyerberg J (1989) Coronary heart disease in Greenland Inuit: a paradox. Implications for Western diet patterns. Arctic Med Res 48, 47-54.
16. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
17. Wergedahl H, Liaset B, Gudbrandsen OA, et al. (2004) Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134, 1320-1327.
18. Murano I, Zingaretti MC & Cinti S (2005) The adipose organ of SV129 mice contains a prevalence of brown adipocytes and shows plasticity after cold exposure. Adipocytes 2, 121-130.
19. Association of Official Analytical Chemists (1990) Official Methods of Analysis, 15th ed. Arlington,VA: AOAC.
20. Jensen J, Jebens E, Brennesvik EO, et al. (2006) Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling. Am J Physiol Endocrinol Metab 290, E154-E162.
21. Berge RK, Flatmark T & Osmundsen H (1984) Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Eur J Biochem 141, 637-644.
22. Gudbrandsen OA, Wergedahl H, Liaset B, et al. (2005) Dietary proteins with high isoflavone content or low methionine-glycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94, 321-330.
23. Madsen L, Froyland L, Dyroy E, et al. (1998) Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. J Lipid Res 39, 583-593.
24. Small GM, Burdett K & Connock MJ (1985) A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227, 205-210.
25. Caesar R & Drevon CA (2008) Pancreatic contamination of mesenteric adipose tissue samples can be avoided by adjusted dissection procedures. J Lipid Res 49, 1588-1594.
26. Yusuf S, Hawken S, Ounpuu S, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952.
27. Pais P, Pogue J, Gerstein H, et al. (1996) Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 348, 358-363.
28. Dagenais GR, Yi Q, Mann JF, et al. (2005) Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 149, 54-60.
29. Kusunoki M, Tsutsumi K, Hara T, et al. (2003) Ethyl icosapentate (omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Metabolism 52, 30-34.
30. Pérez-Matute P, Perez-Echarri N, Martinez JA, et al. (2007) Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-a. Br J Nutr 97, 389-398.
31. Kelly IE, Han TS, Walsh K, et al. (1999) Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 22, 288-293.
32. Carey DG, Cowin GJ, Galloway GJ, et al. (2002) Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]. Obes Res 10, 1008-1015.
33. Fissoune R, Pellet N, Chaabane L, et al. (2004) Evaluation of adipose tissue distribution in obese fa/fa Zucker rats by in vivo MR imaging: effects of peroxisome proliferator-activated receptor agonists. MAGMA 17, 229-235.
34. Xu HE, Lambert MH, Montana VG, et al. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3, 397-403.
35. Forman BM, Chen J & Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors a and d. Proc Natl Acad Sci U S A 94, 4312-4317.
36. de Souza CJ, Eckhardt M, Gagen K, et al. (2001) Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50, 1863-1871.
37. Chambrier C, Bastard JP, Rieusset J, et al. (2002) Eicosapentaenoic acid induces mRNA expression of peroxisome proliferatoractivated receptor g. Obes Res 10, 518-525.
38. Aas V, Rokling-Andersen MH, Kase ET, et al. (2005) Eicosapentaenoic acid (20 : 5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells. J Lipid Res 47, 366-374.
39. Semple RK, Chatterjee VK & O'Rahilly S (2006) PPARg and human metabolic disease. J Clin Invest 116, 581-589.
40. Guan HP, Li Y, Jensen MV, et al. (2002) A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 8, 1122-1128.
41. Tan GD, Debard C, Tiraby C, et al. (2003) A 'futile cycle' induced by thiazolidinediones in human adipose tissue? Nat Med 9, 811-812.
42. Halvorsen B, Rustan AC, Madsen L, et al. (2001) Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats. Ann Nutr Metab 45, 30-37.
43. Froyland L, Madsen L, Vaagenes H, et al. (1997) Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 38, 1851-1858.
44. Opal SM & DePalo VA (2000) Anti-inflammatory cytokines. Chest 117, 1162-1172.
45. Nielsen AR & Pedersen BK (2007) The biological roles of exercise- induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32, 833-839.
46. Pedersen BK, Akerstrom TC, Nielsen AR, et al. (2007) Role of myokines in exercise and metabolism. J Appl Physiol 103, 1093-1098.
47. Einstein FH, Atzmon G, Yang XM, et al. (2005) Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54, 672-678.
48. Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443-477.